Trial Design Solutions

31. Trials Designed Around The Patient 2/2/2021

    In traditional site-based trials, high patient burden and difficulties reaching diverse populations often result in under-performing studies. IQVIA Virtual Trials brings studies directly to patients wherever they are — as a 100% remote study or as a hybrid study where patient-centric elements are built into a traditional site-based trial. Trials designed around the patient: a more efficient, more flexible approach to clinical research.

32. Increase The Probability Of Regulatory And Technical Success 2/22/2021

    To mitigate the uncertain clinical trial landscape and make better data-driven decisions, clinical development groups have turned towards real world data (RWD) to augment and inform their understanding of the disease and treatment landscape. Integrated Evidence from Acorn AI provides access to a one of a kind cross-sponsor, regulatory grade, patient-level clinical trial dataset with pre-integrated real world assets to help clinical developers make critical data-driven decisions throughout the product development lifecycle and increase their probability of success.

33. Budget Negotiation Services 10/16/2020

    Negotiation processes can be one of the most time-consuming components during clinical trial startup. Advarra experts can help you alleviate budget negotiation burdens, reach your funding goals, and accelerate your activation timelines.

34. Data Science Brochure 10/31/2018

    Cytel data scientists apply advanced statistical techniques including predictive modeling of biological processes and drug interactions to unlock the potential of big data. Our team supports biomarker discovery and diagnostic test development based on biomedical signals and images, and real world evidence analysis.

35. Solara Software Platform For Clinical Trials 12/8/2020

    Does your most promising statistical design lie in the uncharted shadows between suboptimal choices? Development teams can shave months and millions off the plan and improve likelihood of success by strategically optimizing statistical design.

36. Oracle Health Sciences Analyze Insight For Activate Cloud Service 5/7/2020

    Oracle Analyze Insight for Activate Cloud Service intelligence improves transparency, communication, and collaboration with CROs by providing sponsors with timely status updates and operational insights into outsourced studies with their CRO partners, leading to enhanced performance and governance. Through visually rich analytics and dashboards, we help transition your team from a process that is reactive to one that is more proactive.

37. Quantitative Pharmacology and Pharmacometrics Brochure 10/31/2018

    Exposure and dose response analyses, including pharmacokinetic and pharmacodynamics analyses, guide critical decisions in drug development. Cytel’s expert Quantitative Pharmacology and Pharmacometrics group helps our customers get those decisions right.

38. Adaptive Trial Design and Implementation 10/31/2018

    Cytel brings its expertise in adaptive designs to the design and implementation of the industry’s most innovative clinical trials. These highly flexible trials raise peculiar challenges for enrollment, data collection and regulatory submission. Why not have the industry leaders in adaptive design working on your adaptive trials?

39. Budget Setup Services 10/16/2020

    Advarra’s Budget Setup Service helps your organization manage a large quantity of negotiated budgets, providing resourcing capacity to keep your project moving forward while maintaining financial visibility in your OnCore Enterprise Research System.

40. Optimize Clinical Trial Protocol Development 7/27/2020

    Developing a clinical trial protocol is a critical step in this process. Poorly conceived protocols create challenges at the study level, the program level and across the full lifecycle of development and commercialization. BM® Study Advance helps you build quality protocols by providing the power of collaboration, AI and and real-world data to enable efficiency and informed decisions across protocol design and development.